PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Administration of 25 ml of aqueous distillate after meals for 3 months led to a significantly greater increase in HDL-cholesterol and decreases in LDL-cholesterol, apolipoprotein B, lipoprotein(a), and high sensitivity C-reactive protein compared to control [PMID:19094443].
Essential oil exhibited cytotoxic activity in gastric adenocarcinoma (AGS) cells and demonstrated antiproliferative effects, particularly in HT-29 colorectal cancer cell lines [PMID:40604718, PMID:31323754].
Essential oil inhibited the adhesion and formation of Candida spp. biofilms and reduced formation on pre-coated surfaces by up to 50% [PMID:33915040].
Essential oil administration significantly alleviated learning and memory impairments [PMID:35201555].
Safety & adverse effects
Dosage & administration
Evidence summary
PubMed sources
- 1.PMID: 27062715 (2016) — Medicinal Uses, Phytochemistry, and Pharmacology of Origanum onites (L.): A Review. · Chemistry & biodiversity
- 2.PMID: 36988221 (2024) — Encapsulation of Origanum onites essential oil with different wall material using spray drying. · Phytochemical analysis : PCA
- 3.PMID: 31817023 (2019) — Antiprotozoal Activity of Turkish Origanum onites Essential Oil and Its Components. · Molecules (Basel, Switzerland)
- 4.PMID: 40604718 (2025) — The anticancer potential of Origanum onites L. in gastric cancer through epigenetic alterations. · BMC complementary medicine and therapies
- 5.PMID: 37585891 (2023) — Effect of Dietary Origanum onites on Growth, Non Specific Immunity and Resistance against Yersinia ruckeri of Rainbow Trout ( Oncorhynchus mykiss).